Epsilico
Epsilico develops biopharmaceuticals and biologics to address diseases with unmet need. It uses generative AI to design effective and safe biologics. As a biotechnology company, it operates in the biopharma space serving research and development teams. Core technology includes AI-driven design, protein engineering, and biologics development workflows. The company aims to scale in biotech markets through collaborations and partnerships with pharma and research organizations.
Epsilico
Epsilico develops biopharmaceuticals and biologics to address diseases with unmet need. It uses generative AI to design effective and safe biologics. As a biotechnology company, it operates in the biopharma space serving research and development teams. Core technology includes AI-driven design, protein engineering, and biologics development workflows. The company aims to scale in biotech markets through collaborations and partnerships with pharma and research organizations.